NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CorWave

CorWave

Private
ClichyHealthcare & Life Scienceshttps://www.corwave.com/

Last Round

Series C

Jun 20, 2023

Total Funding Raised

$154.04M

Company Overview

CorWave is a medical device company that develops innovative heart-assist pumps to bring a reliable and sustainable solution to heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

left ventricular assist deviceLVADheart pumpmechanical circulatory supportartificial heartimplantable medical devicepulsatile flowcardiovascular surgeryheart failure treatmentmedical technologyclinical trialswave membrane technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CorWave Comparables

Compare CorWave with similar companies based on industry and business-model similarity.

CorWave comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FineHeart
87%
BrioHealth Solutions
84%
Shenzhen Core Medical Technology Co., Ltd.
83%

CorWave Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 20, 2023
Series CJan 6, 2021
GrantNov 19, 2020
GrantJul 21, 2020
GrantJun 10, 2020
Grant
Jul 10, 2018

Key People

Founding team and executive leadership

Louis de Lillers

CEO

Executive Team

Andreas Fleischli

Chief Technology Officer

Executive Team

Carl Botterbusch

Chief Technology Officer

Executive Team

CorWave Investors

Notable investors and investment history

CorWave investors
InvestorRounds
Programme d'Investissements d'AvenirSeries C
European Innovation Council FundSeries C, Grant
Ikigai Growth PartnersSeries C
Montpensier ArbevelSeries C
Ysios CapitalSeries C, Series B
BpifranceSeries B, Grant, Series C
Novo HoldingsSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 29, 2025

    Will present at the HFSA Annual Scientific Meeting.

  • Sep 29, 2025

    Presenting first-in-human implant study results at HFSA Annual Scientific Meeting.

CorWave Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CorWave Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CorWave's valuation, stock price, and market status.

Firmographic Details

HeadquartersClichy
Employee Range124
Year Founded2012
Last FundingJun 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.